Fig. 2: Survival outcomes by FLT3 numerical variation, length and allelic ratio.

Overall survival and relapse free survival for all patients receiving FLT3 inhibitors (a, b) based on FLT3-ITD numerical variation (single versus multiple) (c, d) FLT3-ITD mutation length (Long versus Short) (e, f) FLT3-ITD allelic ratio (high ≥0.5, low <0.5).